Trial intelligence / Profile preview

Effectiveness of Botulinum Toxin Infiltration for Treatment of Upper Limb Dysfunctions After Breast Cancer

2014-005114-33Phase 3Completed

Sponsor
UZ Leuven
Start
Jan 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Upper Limb Dysfunction and breast cancer comparing Botox + physical therapy with Placebo + physical therapy (2 arms). Primary endpoint: Change in pain and upper limb dysfunction from baseline. Started Jan 2015; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Upper Limb Dysfunctionbreast cancer

Beyond the preview

Go deeper on 2014-005114-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005114-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call